Powder: -20°C for 3 years | In solvent: -80°C for 1 year
α-Glucosidase-IN-18 (7B) is an orally active inhibitor of α-glucosidase, displaying an IC 50 value of 3.96 μM. This compound exhibits antidiabetic properties [1].
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
25 mg | ¥ 10,600 | 10-14周 | ||
50 mg | ¥ 13,800 | 10-14周 | ||
100 mg | ¥ 17,500 | 10-14周 |
产品描述 | α-Glucosidase-IN-18 (7B) is an orally active inhibitor of α-glucosidase, displaying an IC 50 value of 3.96 μM. This compound exhibits antidiabetic properties [1]. |
体内活性 | α-Glucosidase-IN-18 (7B) (p.o., 10 or 20 mg/kg) has antidiabetic activity and significantly reduces blood glucose levels, from 392.16 mg/dL of diabetic control to 112.97 mg/dL at a concentration of 20 mg/kg after 28 days, while effectively slowing weight loss due to diabetes in male Wistar albino rats with streptozotocin-induced diabetes [1]. α-Glucosidase-IN-18 (7B) (p.o., 10 or 20 mg/kg) had an anti-hyperlipidemic effect with total CH levels from 226.03 mg/dL in the diabetic control to 136.4 mg/dL, LDL levels from 183.3 mg/dL to 114.18 mg/dL and TG levels from 189.35 mg/dL to 118.61 mg/dL in male Wistar albino rats with streptozotocin-induced diabetes [1]. α-Glucosidase-IN-18 (7B) decreases ALP levels from 3.01 mg/dL to 0.85 mg/dL and 0.79 mg/dL, SGPT levels from 59.43 mg/dL to 27.07 mg/dL and 23.91 mg/dL, SGOT levels from 49.67 mg/dL to 26.71 mg/dL and 23.08 mg/dL, serum creatinine from 3.01 mg/dL to 0.85 mg/dL and 0.79 mg/dL, and insulin levels from 0.369 mg/dL to 0.621 mg/dL and 0.639 mg/dL, respectively at doses of 10 and 20 mg/kg in male Wistar albino rats with streptozotocin-induced diabetes [1]. |
分子量 | 373.47 |
分子式 | C23H19NO2S |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
α-Glucosidase-IN-18 Inhibitor inhibitor inhibit